Presymptomatic treatment for Alzheimer #39;s disease: feasible or fanciful? (15 Nov 2012)
Prof Nick Fox, Professor of Neurology, UCL Institute of Neurology, UCL Brain Sciences Alzheimer #39;s disease affects an estimated 400000 people in the UK -- that number will double over coming decades without treatments to delay or prevent disease. We are now able to #39;see #39; the earliest brain changes of Alzheimer #39;s disease, which can appear years before first symptoms, opening up the possibility of presymptomatic trials. With serial imaging and videos of patients and at-risk individuals this lecture considers the potential and problems for such trials.From:UCLLHLViews:0 0ratingsTime:29:55More inEducation<\/p>\n
More here: Presymptomatic treatment for Alzheimer's disease: feasible or fanciful? (15 Nov 2012) Prof Nick Fox, Professor of Neurology, UCL Institute of Neurology, UCL Brain Sciences Alzheimer's disease affects an estimated 400000 people in the UK -- that number will double over coming decades without treatments to delay or prevent disease Continue reading
\nPresymptomatic treatment for Alzheimer's disease: feasible or fanciful? (15 Nov 2012) - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"